Jaguar Health, Inc. cotiza a 4.64 USD y tiene una capitalización bursátil de $9M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Jaguar Health, Inc., a commercial-stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress. It operates through two segments, Animal Health and Human Health. The company focuses on developing and commercializing prescription and non-pr…
| Periodo | 2026-11 | 2026-08 | 2025-11 | 2025-08 |
|---|---|---|---|---|
| Real | — | — | $-3297.00 | $-3888.94 |
| Estimado | $-614.25 | $-52.15 | $-2667.00 | $-3743.25 |
| Sorpresa | — | — | -23.6% | -3.9% |
| Métrica | JAGX | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 67.2% | 57.0% | +10.2% |
| Operating Margin | -398.8% | -38.6% | -360.2% |
| Net Margin | -465.4% | -33.6% | -431.9% |
| FCF Margin | — | -13.9% | — |
| ROE | — | -40.4% | — |
| ROA | -139.8% | -32.0% | -107.8% |
| Current Ratio | 0.50 | 2.84 | -2.34 |
| Debt / Equity | -0.81 | 0.28 | -1.09 |